Form 4 for IRMD IRADIMED CORP
Accepted 2021-11-30 00:00:00 ET · period of report 2021-11-26 · accession 0000898432-21-000745 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-30 | 2021-11-26+ | IRMD | HAWKINS JAMES B | Dir | S - Sale | $45.60 | -17.8K | 17.3K | -51% | -$810.2K |
| DM | 2021-11-30 | 2021-11-26+ | IRMD | HAWKINS JAMES B | Dir | A - Grant | $1.48 | +17.8K | 21.6K | +463% | +$26.3K |
| DM | 2021-11-30 | 2021-11-26+ | IRMD | HAWKINS JAMES B | Dir | M - OptEx | $0.00 | -17.8K | 28.7K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-29 | S | D | 12,176 | $46.11 | 17,268 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $44.44 to $46.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2021-11-30 | S | D | 1,257 | $46.23 | 17,268 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $46.20 to $46.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-11-30 | A | A | 1,257 | $1.48 | 18,525 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 4 | Common | Common Stock | 2021-11-29 | A | A | 12,176 | $1.48 | 29,444 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 5 | Common | Common Stock | 2021-11-26 | S | D | 4,332 | $44.00 | 17,268 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-26 | A | A | 4,332 | $1.48 | 21,600 | D | — | — | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 7 | Derivative | Stock Options (Right to Buy) | 2021-11-26 | M | D | 4,332 | $0.00 | 42,176 | D | $1.48 · — to 2023-12-31 | 4,332 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 8 | Derivative | Stock Options (Right to Buy) | 2021-11-29 | M | D | 12,176 | $0.00 | 30,000 | D | $1.48 · — to 2023-12-31 | 12,176 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |
| 9 | Derivative | Stock Options (Right to Buy) | 2021-11-30 | M | D | 1,257 | $0.00 | 28,743 | D | $1.48 · — to 2023-12-31 | 1,257 Common Stock | (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date. |